This site is intended for UK healthcare professionals only.

Sit down, sit back, relax

This is your Prostap DCS comfort zone. A site where you can learn about Prostap DCS, explore the injection and its safety device in detail and order materials to help support your prostate cancer patients.

Contact

If you are a healthcare professional and have a query about Prostap DCS, please call Medical Information on:

01628 537 900

If you would like to find out more about how Prostap DCS can help your practice save money, or to order, please call CLARITYpharma on:

0845 080 5190

If you are a healthcare professional and would like to be contacted about Prostap DCS,
please enter your details in the short form below

Your Name
Email
Phone
Definition of Role
Practice address
Postcode
*Required fields

Takeda UK Ltd will NOT share any of your details with any other parties. If at any time you wish to unsubscribe from receiving information about Prostap DCS, please call Takeda UK Ltd on 01628 537 900.

References

  1. IMS Midas standard unit sales. (1,000) MAT/JAN/2014.
  2. Takeda UK Ltd. Data on file, DF120604(2).
  3. The Leuprolide Study Group. N Eng J Med 1984;311:1281–1286
  4. Sharifi R, Ratanawong C et al. Advanced Drug Delivery Reviews 1977;28:121–138.
  5. D’Amico A V, Chen M et al. JAMA 2008;299:289–295
  6. Kienle E, Lubben G. Urol Int 1996;56(Suppl 1):23–30.
  7. Tunn U W, Wiedey K. Prostate Cancer Prostatic Dis 2009;12:83–87
  8. Prostap SR DCS. Summary of Product Characteristics.
  9. Prostap 3 DCS. Summary of Product Characteristics.
  10. Takeda UK Ltd. Data on file, UK/DF/1405/0020.
  11. Health and Safety Sharp Instruments in Healthcare Regulations 2013. Available at: http://www.hse.gov.uk/pubns/hsis7.pdf.
  12. National Institute for Health and Care Excellence (NICE). Clinical guideline CG175. Full guideline, 2014.
  13. Abdouelfadel Z & Crawford D. Therapeut Clin Risk Manag 2008;4(2):513–526
  14. Barnes R et al. Study M86-049 Report.
  15. MHRA Prostap® SR DCS UKPAR, 2014. Available at: http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con120
    442.pdf.
  16. Jocham D. Urol Int 1998;60:18–24.
  17. Mottet N et al. European Association of Urology Guidelines on Prostate Cancer, Update March 2015. Available at: http://www.uroweb.org.
  18. D’Amico et al.JAMA 2004;292(7):821–827.
  19. Mottet N et al. Eur Urol 2012;62:213–219.
  20. Wechsel HW et al. Eur Urol 1996;30(Suppl 1):7–14.
  21. Takeda UK Ltd. Data on file. DF121104.
  22. Takeda UK Ltd. Data on file. DF121106.

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for Practice Managers.

If you are not a Practice Manager, please select the appropriate area of this website from the welcome page.

No

I am not a
Practice Manager

Yes

I am a
Practice Manager

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for Healthcare Professionals.

If you are not a Healthcare Professional, please select NO to go back and select the appropriate section of this website for you.

No

I am not a Healthcare Professional

Yes

I am a Healthcare Professional

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for patients who have been prescribed Prostap DCS.

If you are not a patient who has been prescribed Prostap DCS, please select the appropriate area of this website from the welcome page.

No

I am not a Prostap DCS prescribed patient.

Yes

I am a Prostap DCS prescribed patient.